Business Context and Reporting Period
Company: Prothena Corporation plc
Filing Type: Form 8-K (Current Report)
Date of Report: January 29, 2014
Event: Entry into a Material Definitive Agreement regarding a secondary offering of ordinary shares.
Key Financial Metrics
This filing reports a secondary offering by a selling shareholder and does not contain standard financial performance metrics (revenue, profit, cash flow, margins, or debt) for the Company.
- Shares Sold: 2,767,177 ordinary shares by Elan Science One Limited (Selling Shareholder).
- Public Offering Price: $26.00 per share.
- Price to Selling Shareholder: $24.96 per share.
- Over-Allotment Option: Underwriters granted an option to purchase up to an additional 415,076 shares.
- Company Proceeds: $0. The Company will not receive any proceeds from this transaction.
Material Changes
The filing discloses a material change in the Company's capital structure due to the issuance of new shares by a selling shareholder. This transaction increases the number of outstanding shares available to the public but does not alter the Company's cash position or debt levels.
Guidance, Outlook, and Risks
Management Commentary: The filing contains no forward-looking guidance, outlook, or management commentary regarding business operations or financial projections.
Risks and Contingencies: The Underwriting Agreement includes customary representations, warranties, covenants, and indemnification provisions. The offering is subject to the terms of the registration statement on Form S-3 (Reg. No. 333-193416).
Investor Verification Checklist
- Verify the total number of outstanding shares post-offering to assess potential dilution.
- Confirm that the Company received no proceeds from this specific transaction.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific lock-up provisions or future obligations.
- Check the status of the over-allotment option exercisable within 30 days of January 29, 2014.